What is Jays?
Jays operates as a critical intermediary in the healthcare procurement ecosystem, serving as a comprehensive supplier for pharmacies, hospitals, clinics, and veterinary practices. By acting as a centralized distributor for over 50 distinct suppliers, the company streamlines the acquisition of essential packaging and medical supplies. Beyond standard distribution, Jays distinguishes itself through value-added services such as custom imprinting, which allows healthcare providers to integrate branding directly into their clinical supplies. This dual-focus on logistical efficiency and personalized product solutions has enabled the company to maintain a competitive edge in a fragmented market, ensuring that thousands of nationwide clients receive high-quality materials at optimized price points.
How much funding has Jays raised?
Jays has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Jays
PPP
Public-Private Partnership
What's next for Jays?
With the infusion of this late-stage capital, Jays is well-positioned to scale its infrastructure and deepen its market penetration. The strategic roadmap likely involves expanding its supplier network and investing in advanced inventory management systems to further reduce lead times for its diverse client base. As the healthcare industry continues to prioritize supply chain resilience, Jays is poised to leverage its established relationships and custom branding expertise to capture additional market share. Future growth will likely focus on digitizing the procurement experience and enhancing the scalability of its custom imprinting services to meet the evolving needs of modern medical facilities.
See full Jays company page
